Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma. [electronic resource]
Producer: 19960705Description: 2302-7 p. digitalISSN:- 0008-543X
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Combined Modality Therapy
- Cytarabine -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Etoposide -- administration & dosage
- Female
- Follow-Up Studies
- Granulocyte Colony-Stimulating Factor -- pharmacology
- Hematopoietic Stem Cell Transplantation
- Humans
- Ifosfamide -- administration & dosage
- Life Tables
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Neoplasm Recurrence, Local
- Prognosis
- Recombinant Proteins -- pharmacology
- Remission Induction
- Salvage Therapy
- Survival Analysis
- Treatment Outcome
- Whole-Body Irradiation
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.